These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 19246717)

  • 1. Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.
    Ferreira AJ; Shenoy V; Yamazato Y; Sriramula S; Francis J; Yuan L; Castellano RK; Ostrov DA; Oh SP; Katovich MJ; Raizada MK
    Am J Respir Crit Care Med; 2009 Jun; 179(11):1048-54. PubMed ID: 19246717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.
    Shenoy V; Ferreira AJ; Qi Y; Fraga-Silva RA; Díez-Freire C; Dooies A; Jun JY; Sriramula S; Mariappan N; Pourang D; Venugopal CS; Francis J; Reudelhuber T; Santos RA; Patel JM; Raizada MK; Katovich MJ
    Am J Respir Crit Care Med; 2010 Oct; 182(8):1065-72. PubMed ID: 20581171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro.
    Haber PK; Ye M; Wysocki J; Maier C; Haque SK; Batlle D
    Hypertension; 2014 Apr; 63(4):774-82. PubMed ID: 24446061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases.
    Ferreira AJ; Shenoy V; Qi Y; Fraga-Silva RA; Santos RA; Katovich MJ; Raizada MK
    Exp Physiol; 2011 Mar; 96(3):287-94. PubMed ID: 21148624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension.
    Shenoy V; Kwon KC; Rathinasabapathy A; Lin S; Jin G; Song C; Shil P; Nair A; Qi Y; Li Q; Francis J; Katovich MJ; Daniell H; Raizada MK
    Hypertension; 2014 Dec; 64(6):1248-59. PubMed ID: 25225206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of pulmonary hypertension by Angiotensin-converting enzyme 2 gene transfer.
    Yamazato Y; Ferreira AJ; Hong KH; Sriramula S; Francis J; Yamazato M; Yuan L; Bradford CN; Shenoy V; Oh SP; Katovich MJ; Raizada MK
    Hypertension; 2009 Aug; 54(2):365-71. PubMed ID: 19564552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the vasoprotective axis of the renin-angiotensin system: a novel strategic approach to pulmonary hypertensive therapy.
    Bradford CN; Ely DR; Raizada MK
    Curr Hypertens Rep; 2010 Aug; 12(4):212-9. PubMed ID: 20556668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction.
    Murça TM; Moraes PL; Capuruço CA; Santos SH; Melo MB; Santos RA; Shenoy V; Katovich MJ; Raizada MK; Ferreira AJ
    Regul Pept; 2012 Aug; 177(1-3):107-15. PubMed ID: 22595130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.
    Li G; Liu Y; Zhu Y; Liu A; Xu Y; Li X; Li Z; Su J; Sun L
    Lung; 2013 Aug; 191(4):327-36. PubMed ID: 23652350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme 2 activation protects against pulmonary arterial hypertension through improving early endothelial function and mediating cytokines levels.
    Li G; Xu YL; Ling F; Liu AJ; Wang D; Wang Q; Liu YL
    Chin Med J (Engl); 2012 Apr; 125(8):1381-8. PubMed ID: 22613639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.
    Chen IC; Lin JY; Liu YC; Chai CY; Yeh JL; Hsu JH; Wu BN; Dai ZK
    Int J Med Sci; 2020; 17(16):2594-2602. PubMed ID: 33029102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme 2 activation improves endothelial function.
    Fraga-Silva RA; Costa-Fraga FP; Murça TM; Moraes PL; Martins Lima A; Lautner RQ; Castro CH; Soares CM; Borges CL; Nadu AP; Oliveira ML; Shenoy V; Katovich MJ; Santos RA; Raizada MK; Ferreira AJ
    Hypertension; 2013 Jun; 61(6):1233-8. PubMed ID: 23608648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
    Hampl V; Herget J; Bíbová J; Baňasová A; Husková Z; Vaňourková Z; Jíchová Š; Kujal P; Vernerová Z; Sadowski J; Červenka L
    Physiol Res; 2015; 64(1):25-38. PubMed ID: 25194138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New targets in pulmonary hypertension--another ACE up the sleeve.
    Yin J; Kuebler WM
    Am J Respir Crit Care Med; 2009 Sep; 180(5):481-2; author reply 482. PubMed ID: 19700568
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-β cascades with restored caveolin-1 expression.
    Haga S; Tsuchiya H; Hirai T; Hamano T; Mimori A; Ishizaka Y
    Exp Lung Res; 2015 Feb; 41(1):21-31. PubMed ID: 25275723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
    Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2.
    Han SX; He GM; Wang T; Chen L; Ning YY; Luo F; An J; Yang T; Dong JJ; Liao ZL; Xu D; Wen FQ
    Toxicol Appl Pharmacol; 2010 May; 245(1):100-7. PubMed ID: 20178811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat.
    Dang Z; Su S; Jin G; Nan X; Ma L; Li Z; Lu D; Ge R
    J Ethnopharmacol; 2020 Mar; 250():112470. PubMed ID: 31862407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.
    Singh N; Joshi S; Guo L; Baker MB; Li Y; Castellano RK; Raizada MK; Jarajapu YP
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1697-707. PubMed ID: 26386115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Acetyl-Seryl-Asparyl-Lysyl-Proline regulates lung renin angiotensin system to inhibit epithelial-mesenchymal transition in silicotic mice.
    Li S; Li Y; Zhang Y; Li S; Zhang M; Jin F; Wei Z; Yang Y; Gao X; Mao N; Ge X; Xu H; Yang F
    Toxicol Appl Pharmacol; 2020 Dec; 408():115255. PubMed ID: 33007385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.